This has revealed an inflammatory signature, which can frequently be tightly associated with NF-κB regulation, in a variety of tumors such as glioblastoma, breast, prostate, and ovarian cancers [94,95,96,97,98,99]. Here, NFKB1 is linked to ovarian cancer.